Kentaro Iwaki, Tomoaki Yoh, Hiroto Nishino, Takahiro Nishio, Yukinori Koyama, Satoshi Ogiso, Takamichi Ishii, Masashi Kanai, Etsuro Hatano. Completion of adjuvant S-1 chemotherapy after surgical resection for biliary tract cancer: A single center experience. Asian journal of surgery. 2023
Kuniko Sunami, Yoichi Naito, Yusuke Saigusa, Toraji Amano, Daisuke Ennishi, Mitsuho Imai, Hidenori Kage, Masashi Kanai, Hirotsugu Kenmotsu, Keigo Komine, et al. A Learning Program for Treatment Recommendations by Molecular Tumor Boards and Artificial Intelligence. JAMA oncology. 2023
Toshihiko Masui, Kazuyuki Nagai, Takayuki Anazawa, Yosuke Kasai, Akitada Yogo, Michio Yoshimura, Takashi Mizowaki, Norimitsu Uza, Akihisa Fukuda, Shigemi Matsumoto, et al. Safety and efficacy of neoadjuvant chemoradiotherapy with moderately hypofractionated intensity-modulated radiotherapy for resectable pancreatic cancer: A prospective, open-label, phase II study. Cancer medicine. 2023. 12. 18. 18611-18621
Hiroshi Imaoka, Masafumi Ikeda, Kumiko Umemoto, Yu Sunakawa, Makoto Ueno, Hideki Ueno, Masato Ozaka, Takamichi Kuwahara, Naohiro Okano, Masashi Kanai, et al. Comprehensive review of undifferentiated carcinoma of the pancreas: from epidemiology to treatment. Japanese journal of clinical oncology. 2023
Tomohiro Kondo, Masashi Kanai, Junichi Matsubara, Daisuke Yamaguchi, Takashi Ura, Tadayuki Kou, Toshinao Itani, Motoo Nomura, Taro Funakoshi, Akira Yokoyama, et al. Association between homologous recombination gene variants and efficacy of oxaliplatin-based chemotherapy in advanced pancreatic cancer: prospective multicenter observational study. Medical oncology (Northwood, London, England). 2023. 40. 5. 144-144
Therapeutic application of highly bioavailable curcumin for patients with cancer
(The second International Conference on Pharma and Food, Shizuoka 2014)
The current gideline of pancreatic cancer in Japan
(Shanghai International Conference on Pancreatic Cancer 2014)